Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Alternative splicing of hepatitis B virus: A novel virus/host interaction altering liver immunity.

Duriez M, Mandouri Y, Lekbaby B, Wang H, Schnuriger A, Redelsperger F, Guerrera CI, Lefevre M, Fauveau V, Ahodantin J, Quetier I, Chhuon C, Gourari S, Boissonnas A, Gill U, Kennedy P, Debzi N, Sitterlin D, Maini MK, Kremsdorf D, Soussan P.

J Hepatol. 2017 Oct;67(4):687-699. doi: 10.1016/j.jhep.2017.05.025. Epub 2017 Jun 7.

2.

NK cells control HIV-1 infection of macrophages through soluble factors and cellular contacts in the human decidua.

Quillay H, El Costa H, Duriez M, Marlin R, Cannou C, Madec Y, de Truchis C, Rahmati M, Barré-Sinoussi F, Nugeyre MT, Menu E.

Retrovirology. 2016 Jun 6;13(1):39. doi: 10.1186/s12977-016-0271-z.

3.

The local environment orchestrates mucosal decidual macrophage differentiation and substantially inhibits HIV-1 replication.

El Costa H, Quillay H, Marlin R, Cannou C, Duriez M, Benjelloun F, de Truchis C, Rahmati M, Ighil J, Barré-Sinoussi F, Nugeyre MT, Menu E.

Mucosal Immunol. 2016 May;9(3):634-46. doi: 10.1038/mi.2015.87. Epub 2015 Sep 9.

4.

Distinct characteristics of endometrial and decidual macrophages and regulation of their permissivity to HIV-1 infection by SAMHD1.

Quillay H, El Costa H, Marlin R, Duriez M, Cannou C, Chrétien F, Fernandez H, Lebreton A, Ighil J, Schwartz O, Barré-Sinoussi F, Nugeyre MT, Menu E.

J Virol. 2015 Jan 15;89(2):1329-39. doi: 10.1128/JVI.01730-14. Epub 2014 Nov 12.

5.

Human decidual macrophages and NK cells differentially express Toll-like receptors and display distinct cytokine profiles upon TLR stimulation.

Duriez M, Quillay H, Madec Y, El Costa H, Cannou C, Marlin R, de Truchis C, Rahmati M, Barré-Sinoussi F, Nugeyre MT, Menu E.

Front Microbiol. 2014 Jul 1;5:316. doi: 10.3389/fmicb.2014.00316. eCollection 2014.

6.

Conserved aromatic residues of the hepatitis B virus Precore propeptide are involved in a switch between distinct dimeric conformations and essential in the formation of heterocapsids.

Duriez M, Thouard A, Bressanelli S, Rossignol JM, Sitterlin D.

Virology. 2014 Aug;462-463:273-82. doi: 10.1016/j.virol.2014.06.013. Epub 2014 Jul 5.

7.

Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice.

Quétier I, Brezillon N, Duriez M, Massinet H, Giang E, Ahodantin J, Lamant C, Brunelle MN, Soussan P, Kremsdorf D.

J Hepatol. 2013 Aug;59(2):285-91. doi: 10.1016/j.jhep.2013.03.021. Epub 2013 Mar 28.

PMID:
23542345
8.

Production of hepatitis B defective particles is dependent on liver status.

Redelsperger F, Lekbaby B, Mandouri Y, Giang E, Duriez M, Desire N, Roque Afonso AM, Brichler S, Dubreuil P, Dobrin A, Perlemuter G, Prevot S, Bacon N, Grange JD, Zatla F, Le Pendeven C, Pol S, Strick-Marchand H, Di Santo J, Kremsdorf D, Soussan P.

Virology. 2012 Sep 15-30;431(1-2):21-8. doi: 10.1016/j.virol.2012.05.008. Epub 2012 Jun 2.

9.

C/EBP homologous protein-10 (CHOP-10) limits postnatal neovascularization through control of endothelial nitric oxide synthase gene expression.

Loinard C, Zouggari Y, Rueda P, Ramkhelawon B, Cochain C, Vilar J, Récalde A, Richart A, Charue D, Duriez M, Mori M, Arenzana-Seisdedos F, Lévy BI, Heymes C, Silvestre JS.

Circulation. 2012 Feb 28;125(8):1014-26. doi: 10.1161/CIRCULATIONAHA.111.041830. Epub 2012 Jan 20.

PMID:
22265908
10.

Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy.

Marlin R, Duriez M, Berkane N, de Truchis C, Madec Y, Rey-Cuille MA, Cummings JS, Cannou C, Quillay H, Barré-Sinoussi F, Nugeyre MT, Menu E.

PLoS One. 2012;7(1):e30017. doi: 10.1371/journal.pone.0030017. Epub 2012 Jan 5.

11.

Decidual soluble factors participate in the control of HIV-1 infection at the maternofetal interface.

Marlin R, Nugeyre MT, Duriez M, Cannou C, Le Breton A, Berkane N, Barré-Sinoussi F, Menu E.

Retrovirology. 2011 Jul 18;8:58. doi: 10.1186/1742-4690-8-58.

12.

Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization.

Cochain C, Rodero MP, Vilar J, Récalde A, Richart AL, Loinard C, Zouggari Y, Guérin C, Duriez M, Combadière B, Poupel L, Lévy BI, Mallat Z, Combadière C, Silvestre JS.

Cardiovasc Res. 2010 Oct 1;88(1):186-95. doi: 10.1093/cvr/cvq153. Epub 2010 May 25.

PMID:
20501509
13.

Regulatory T cells modulate postischemic neovascularization.

Zouggari Y, Ait-Oufella H, Waeckel L, Vilar J, Loinard C, Cochain C, Récalde A, Duriez M, Levy BI, Lutgens E, Mallat Z, Silvestre JS.

Circulation. 2009 Oct 6;120(14):1415-25. doi: 10.1161/CIRCULATIONAHA.109.875583. Epub 2009 Sep 21. Erratum in: Circulation. 2010 Feb 9;121(5):e31. Lutgens, Ester [corrected to Lutgens, Esther].

PMID:
19770391
14.

Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization.

Loinard C, Ginouvès A, Vilar J, Cochain C, Zouggari Y, Recalde A, Duriez M, Lévy BI, Pouysségur J, Berra E, Silvestre JS.

Circulation. 2009 Jul 7;120(1):50-9. doi: 10.1161/CIRCULATIONAHA.108.813303. Epub 2009 Jun 22.

PMID:
19546390
15.

Preconditioning by mitochondrial reactive oxygen species improves the proangiogenic potential of adipose-derived cells-based therapy.

Carrière A, Ebrahimian TG, Dehez S, Augé N, Joffre C, André M, Arnal S, Duriez M, Barreau C, Arnaud E, Fernandez Y, Planat-Benard V, Lévy B, Pénicaud L, Silvestre JS, Casteilla L.

Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1093-9. doi: 10.1161/ATVBAHA.109.188318. Epub 2009 May 7.

PMID:
19423864
16.

CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization.

Leroyer AS, Rautou PE, Silvestre JS, Castier Y, Lesèche G, Devue C, Duriez M, Brandes RP, Lutgens E, Tedgui A, Boulanger CM.

J Am Coll Cardiol. 2008 Oct 14;52(16):1302-11. doi: 10.1016/j.jacc.2008.07.032.

17.

The hepatitis B virus precore protein is retrotransported from endoplasmic reticulum (ER) to cytosol through the ER-associated degradation pathway.

Duriez M, Rossignol JM, Sitterlin D.

J Biol Chem. 2008 Nov 21;283(47):32352-60. doi: 10.1074/jbc.M807178200. Epub 2008 Sep 19.

18.

Chronic hypoxia-induced angiogenesis normalizes blood pressure in spontaneously hypertensive rats.

Vilar J, Waeckel L, Bonnin P, Cochain C, Loinard C, Duriez M, Silvestre JS, Lévy BI.

Circ Res. 2008 Sep 26;103(7):761-9. doi: 10.1161/CIRCRESAHA.108.182758. Epub 2008 Aug 14.

PMID:
18703778
19.

Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents.

You D, Cochain C, Loinard C, Vilar J, Mees B, Duriez M, Lévy BI, Silvestre JS.

Hypertension. 2008 Jun;51(6):1537-44. doi: 10.1161/HYPERTENSIONAHA.107.109066. Epub 2008 Apr 21.

PMID:
18426993
20.

Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.

You D, Cochain C, Loinard C, Vilar J, Mees B, Duriez M, Lévy BI, Silvestre JS.

J Pharmacol Exp Ther. 2008 Jun;325(3):766-73. doi: 10.1124/jpet.107.131532. Epub 2008 Feb 28.

PMID:
18309090
21.

NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes.

Ebrahimian TG, Heymes C, You D, Blanc-Brude O, Mees B, Waeckel L, Duriez M, Vilar J, Brandes RP, Levy BI, Shah AM, Silvestre JS.

Am J Pathol. 2006 Aug;169(2):719-28.

22.

Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy.

You D, Waeckel L, Ebrahimian TG, Blanc-Brude O, Foubert P, Barateau V, Duriez M, Lericousse-Roussanne S, Vilar J, Dejana E, Tobelem G, Lévy BI, Silvestre JS.

Circulation. 2006 Jul 25;114(4):328-38. Epub 2006 Jul 17.

PMID:
16847153
23.

Tetrapeptide AcSDKP induces postischemic neovascularization through monocyte chemoattractant protein-1 signaling.

Waeckel L, Bignon J, Liu JM, Markovits D, Ebrahimian TG, Vilar J, Mees B, Blanc-Brude O, Barateau V, Le Ricousse-Roussanne S, Duriez M, Tobelem G, Wdzieczak-Bakala J, Lévy BI, Silvestre JS.

Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):773-9. Epub 2006 Jan 12.

PMID:
16410461
24.

Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization.

Michel F, Silvestre JS, Waeckel L, Corda S, Verbeuren T, Vilaine JP, Clergue M, Duriez M, Levy BI.

Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):488-93. Epub 2005 Dec 29.

PMID:
16385086
25.

[Integrating prevention and promotion in health systems: four realities, diverse similarities].

Bourdages J, Brunelle Y, St-Pierre L, Duriez M, Gerhart C, Jabot F, Nicolas C, Sereda M, Simos JD, von Holzen N, Hartz Zde A, Serrano MM, Bergeron P, Drouin D, Reinharz D, Lamarche PA.

Promot Educ. 2005;Suppl 3:62-4. French.

PMID:
16161854
26.

Lactadherin promotes VEGF-dependent neovascularization.

Silvestre JS, Théry C, Hamard G, Boddaert J, Aguilar B, Delcayre A, Houbron C, Tamarat R, Blanc-Brude O, Heeneman S, Clergue M, Duriez M, Merval R, Lévy B, Tedgui A, Amigorena S, Mallat Z.

Nat Med. 2005 May;11(5):499-506. Epub 2005 Apr 17.

PMID:
15834428
27.

Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3.

Waeckel L, Mallat Z, Potteaux S, Combadière C, Clergue M, Duriez M, Bao L, Gerard C, Rollins BJ, Tedgui A, Levy BI, Silvestre JS.

Circ Res. 2005 Mar 18;96(5):576-82. Epub 2005 Feb 17.

PMID:
15718500
28.

Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice.

Ebrahimian TG, Tamarat R, Clergue M, Duriez M, Levy BI, Silvestre JS.

Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):65-70. Epub 2004 Nov 4.

PMID:
15528473
29.

Aldosterone enhances ischemia-induced neovascularization through angiotensin II-dependent pathway.

Michel F, Ambroisine ML, Duriez M, Delcayre C, Levy BI, Silvestre JS.

Circulation. 2004 Apr 27;109(16):1933-7. Epub 2004 Apr 12.

PMID:
15078792
30.

Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment.

Tamarat R, Silvestre JS, Le Ricousse-Roussanne S, Barateau V, Lecomte-Raclet L, Clergue M, Duriez M, Tobelem G, Lévy BI.

Am J Pathol. 2004 Feb;164(2):457-66.

31.

Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives.

Planat-Benard V, Silvestre JS, Cousin B, André M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C, Duriez M, Tedgui A, Levy B, Pénicaud L, Casteilla L.

Circulation. 2004 Feb 10;109(5):656-63. Epub 2004 Jan 20.

PMID:
14734516
32.

Minimally invasive, in vivo exploration of mouse small artery reactivity.

Michel F, Duriez M, Lévy BI, Boulanger CM.

J Cardiovasc Pharmacol. 2004 Feb;43(2):271-5.

PMID:
14716216
33.

Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition.

Silvestre JS, Gojova A, Brun V, Potteaux S, Esposito B, Duriez M, Clergue M, Le Ricousse-Roussanne S, Barateau V, Merval R, Groux H, Tobelem G, Levy B, Tedgui A, Mallat Z.

Circulation. 2003 Dec 9;108(23):2839-42. Epub 2003 Dec 1.

PMID:
14656923
34.

Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice.

Tamarat R, Silvestre JS, Huijberts M, Benessiano J, Ebrahimian TG, Duriez M, Wautier MP, Wautier JL, Lévy BI.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8555-60. Epub 2003 Jun 12.

35.

Vascular endothelial growth factor-B promotes in vivo angiogenesis.

Silvestre JS, Tamarat R, Ebrahimian TG, Le-Roux A, Clergue M, Emmanuel F, Duriez M, Schwartz B, Branellec D, Lévy BI.

Circ Res. 2003 Jul 25;93(2):114-23. Epub 2003 Jun 12.

PMID:
12805240
36.
37.

Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb.

Mallat Z, Silvestre JS, Le Ricousse-Roussanne S, Lecomte-Raclet L, Corbaz A, Clergue M, Duriez M, Barateau V, Akira S, Tedgui A, Tobelem G, Chvatchko Y, Lévy BI.

Circ Res. 2002 Sep 6;91(5):441-8.

PMID:
12215494
38.

Histomorphometric evaluation of (198)Au endovascular brachytherapy in a renal artery restenosis model in rabbits.

Le Blanche AF, Bonneau M, Wassef M, Farrès MT, Gabez L, Aubert B, Duriez M, Lévy BI, Bigot JM, Boudghene F.

AJR Am J Roentgenol. 2002 Sep;179(3):611-8.

PMID:
12185028
39.

Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb.

Silvestre JS, Tamarat R, Senbonmatsu T, Icchiki T, Ebrahimian T, Iglarz M, Besnard S, Duriez M, Inagami T, Lévy BI.

Circ Res. 2002 May 31;90(10):1072-9.

PMID:
12039796
40.

Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb.

Tamarat R, Silvestre JS, Kubis N, Benessiano J, Duriez M, deGasparo M, Henrion D, Levy BI.

Hypertension. 2002 Mar 1;39(3):830-5.

PMID:
11897773
41.

Increased ischemia-induced angiogenesis in the staggerer mouse, a mutant of the nuclear receptor Roralpha.

Besnard S, Silvestre JS, Duriez M, Bakouche J, Lemaigre-Dubreuil Y, Mariani J, Levy BI, Tedgui A.

Circ Res. 2001 Dec 7;89(12):1209-15.

PMID:
11739287
42.

Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway.

Silvestre JS, Bergaya S, Tamarat R, Duriez M, Boulanger CM, Levy BI.

Circ Res. 2001 Oct 12;89(8):678-83.

PMID:
11597990
43.

Chronic blockade of endothelin receptors improves ischemia-induced angiogenesis in rat hindlimbs through activation of vascular endothelial growth factor-no pathway.

Iglarz M, Silvestre JS, Duriez M, Henrion D, Lévy BI.

Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1598-603.

PMID:
11597932
44.

Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis.

Silvestre JS, Mallat Z, Tamarat R, Duriez M, Tedgui A, Levy BI.

Circ Res. 2001 Aug 3;89(3):259-64.

PMID:
11485976
45.

Endothelium-dependent changes in arterial diameter in old normotensive rats.

Safar M, Duriez M, Corman B, Levy B.

Clin Exp Pharmacol Physiol. 2001 May-Jun;28(5-6):371-5.

PMID:
11380508
46.

[Is there agreement on the determination of public health priorities in Europe?].

Duriez M, Lequet-Slama D, Chambaud L.

Sante Publique. 2000 Dec;12(4):485-96. Review. French.

PMID:
11349333
47.
48.

Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin.

Loufrani L, Matrougui K, Gorny D, Duriez M, Blanc I, Lévy BI, Henrion D.

Circulation. 2001 Feb 13;103(6):864-70.

49.

Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury.

Brocheriou V, Hagège AA, Oubenaïssa A, Lambert M, Mallet VO, Duriez M, Wassef M, Kahn A, Menasché P, Gilgenkrantz H.

J Gene Med. 2000 Sep-Oct;2(5):326-33.

PMID:
11045426
50.

Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb.

Silvestre JS, Mallat Z, Duriez M, Tamarat R, Bureau MF, Scherman D, Duverger N, Branellec D, Tedgui A, Levy BI.

Circ Res. 2000 Sep 15;87(6):448-52.

PMID:
10988235

Supplemental Content

Loading ...
Support Center